Transcriptomics

Dataset Information

Autocrine IGF1 signaling mediates pancreatic tumor cell dormancy in the absence of oncogenic drivers


ABSTRACT: Mutant KRAS and c-MYC are oncogenic drivers and rational therapeutic targets for the treatment of pancreatic cancer. While tumor growth and homeostasis is largely dependent on these oncogenes, a few residual cancer cells are able to survive the ablation of mutant KRAS and c-MYC. By performing a genome-wide gene expression analysis of in vivo-derived bulk tumor cells and residual cancer cells lacking the expression of mutant KRAS or c-MYC, we have identified an increase in autocrine IGF1/AKT signaling as a common survival mechanism in dormant cancer cells. The pharmacological inhibition of IGF-1R reduced residual disease burden and cancer recurrence, suggesting this molecular pathway is crucial for the survival of cancer cells in the absence of the primary oncogenic drivers.

ORGANISM(S): Mus musculus

PROVIDER: GSE93946 | GEO | 2017/02/09

SECONDARY ACCESSION(S): PRJNA362883

REPOSITORIES: GEO